Page 1264 - Clinical Small Animal Internal Medicine
P. 1264

1202  Section 11  Oncologic Disease

            Chemotherapy                                      hormone secretion and appetite stimulation. This has
  VetBooks.ir  Fundamentally, local disease requires a treatment to be   significant  potential  to treat inappetence related to
                                                              chemo therapy  and/or  underlying  cancer  in dogs and
            directed to a specific area, typically surgery or radiation
            therapy. Chemotherapy is often indispensable when pre-  possibly cats. Maropitant citrate (Cerenia®) offers an eco-
                                                              nomical addition to the armament for the prevention
            sented  with  widely  disseminated  but  chemoresponsive   and treatment of chemotherapy‐induced nausea and
            disease (lymphoma) or when the development of meta-  vomiting. In an effort to avoid chemotherapy related tox-
            static disease is highly anticipated (canine osteosar-  icity primarily found in herding breeds an assay is avail-
            coma). The application, administration, and response   able. These breeds  have a higher risk of  toxicity from
            rates achievable through the use of chemotherapy are   chemotherapeutic agents that are actively transported by
            addressed in their respective chapters.
                                                              the p‐glycoprotein pump (e.g., vinca alkaloids, doxoru-
                                                              bicin, dactinomycin, taxanes). The assay is noninvasive,
            Treatment Advances                                and is simply performed through either a blood sample
                                                              or cheek swab. For more information visit www.vetmed.
            Recent treatment advances have provided the veteri-  wsu.edu/depts‐vcpl/.
            narian  with  orally  administered  targeted  treatments
            for  mast cell tumors (Palladia™ and Kinavet‐CA1®).
            TANOVEA®-CA1 (rabacfosadine) is the first FDA con-  Surgery
            ditionally approved drug for the treatment of lymphoma   Surgical intervention is the backbone of localized cancer
            in dogs. This drug is delivered  intravenously  and has   treatment and is often used adjunctively in metastatic
            been found to inhibit the proliferation of lymphoma   cancers.  Surgical  oncology  will  be  addressed  in  the
            cells in vivo. Inter ventional radiology utilizes fluoros-  respective chapters for which is applies.
            copy and endoscopy, placing expandable metallic stents   Interestingly, perioperative anesthetic and analgesic
            in the urethra of dogs  with neoplasia, resulting in   practices, including administration of opioid analgesics
            increased urine flow with tumor obstruction or near‐  and nonsteroidal antiinflammatory drugs (NSAIDs), use
            obstruction. Chemoembolization refers to the angiog-  of local anesthetic techniques, precipitation of the neu-
            raphy guided administration of a vascular occluding   roendocrine stress response, temperature regulation,
            substance and chemotherapy through a catheter into a   and transfusion of blood products may influence long‐
            pinpointed vessel within the tumor. This technique has   term outcomes such as recurrence and metastasis.
            shown promise for the treatment of unresectable liver
            tumors. Hematopoietic stem cell transplantation (HCT)
            is available for dogs with hematopoietic malignancies.   Radiation Therapy
            Immunotherapy research collaboration has provided   Radiation therapy (RT) utilizes the delivery of radiation
            the first USDA‐approved canine melanoma vaccine   from a distance. The delivery of radiation therapy in vet-
            (Oncept®) indicated for aiding in extending survival of   erinary medicine is through the use of three machine
            dogs with stage II or stage III oral  canine melanoma.   types: orthovoltage (infrequently employed), cobalt‐60
            Other available conditionally licensed vaccines include;   (widely used), and linear accelerators (most common).
            Canine Lymphoma Vaccine, a xenogeneic murine      Pedestal machines are limited to up‐and‐down
            CD20 DNA therapeutic vaccine for use in dogs with     movement while isocentric machines rotate around the
            B-cell lymphoma upon achieving remission through   patient. The advantage permits treatment from a variety
            chemotherapy. Canine Osteosarcoma Vaccine for the   of angles. The prescribed radiation dose is expressed as
            treatment of dogs one year or older diagnosed with     tissue  absorbed dose in units of gray (Gy). The total
            appendicular osteosarcoma.  The vaccine is a lyophi-    prescribed radiation is delivered in small defined doses
            lized formulation of a modified-live,attenuated, recom-  called fractions. Radiation therapy is often employed
            binant  HER2/neu–expressing strain of  Listeria  that   when surgical resection of a tumor is limited by normal
            activates cytotoxic T cells. Lastly for our felines, Feline   surrounding structures, and it is not possible to elimi-
            Interleukin-2 (IL-2) Immunomodulator Vaccine may   nate  microscopic  cells.  In  select  cases  when  normal
            delay postsurgical recurrence of feline fibrosarcoma in     tissue structures preclude adequate surgical removal,
            adult cats with stage I disease.                  radiation may be performed prior to surgery (preopera-
             We have also had advancements in treatment‐related   tive). The majority of radiation therapy is performed
            side‐effects, with reports revealing protection from tis-  10–14 days postoperatively.
            sue necrosis associated with administration of dexra-  It is important that the radiation oncologist be aware
            zoxane in patients with chemotherapy extravasation.   of the original tumor site, including the dimensions and
            Entyce®, capromorelin is an orally active small molecule   extent of invasion, so as to include all the affected tis-
            that mimics the action of ghrelin, which causes growth   sue  in the planned radiation field. When microscopic
   1259   1260   1261   1262   1263   1264   1265   1266   1267   1268   1269